By Adam Bonislawski

Executives from Agilent, Bruker, Danaher, Thermo Fisher Scientific, and Waters presented this week at the JP Morgan Healthcare Conference in San Francisco, recapping their firms’ 2011 performances and offering a look forward to 2012.

The academic and government spending concerns that emerged in the second half of last year remained an area of focus. Some vendors, though, professed optimism on that front, with Agilent in particular citing it as an area of opportunity.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.